Bharat Parenterals Ltd

NSE: BPLPHARMA · BSE: 541096 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹1,879.15
Market cap: ₹1,295 Cr
Revenue (annual): ₹345.4 Cr
Net profit (annual): ₹-8.19 Cr
P/E (TTM): -84.1×Sector 47.4×
Promoter holding: 67.20%+0.03% QoQ
FII holding: 0.11%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 4 Earnings Call 4 Promoter Buying 3 Other Announcement 3 Management Change 3 Board Meeting Date 3 Annual General Meeting 2 Price Movement Clarification 1 Dividend 1 Debt & Borrowing 1 Capacity Expansion 1 Business Update 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

21 Apr 2026 13:58 IST BSE

Business Update

Bharat Parenterals Business Update

Bharat Parenterals Limited's subsidiary, Innoxel Lifesciences, concluded a U.S. FDA inspection at its Vadodara facility with five procedural observations under a Voluntary Action Indicated (VAI) classification. The inspection occurred in April 2026. The company maintains its commitment to quality standards and will submit responses within prescribed timelines.

Read the filing ↗